glp-1 receptor agonists and sglt2 inhibitors Diabetic Agents, From Metformin to GLP1 Agonists: JACC Focus Seminar Role of GLP-1 Agonists &

The GLP-1 Receptor Agonist market size reached USD 15.25 Billion in 2024 and is expected to register a revenue CAGR of 21.7%

I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)

Eli Lilly has just launched its newly approved GLP-1 product, Zepbound, in a direct-to-consumer approach

This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes

WEDNESDAY, June 10, 2026 (HealthDay News) -- Continuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into early pregnancy seems not to be associat